| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.03 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |